Hereditary risk and genetic testing at SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
64 organizations at SABCS 2026 present work in hereditary risk and genetic testing, led by cancer centers, hospitals and trial groups. Between them they bring 270 presentations to the program. Most represented: University of California, San Francisco, The Ohio State University and University of Pennsylvania. As of Nov 10, 2026.
| Organization | SABCS 2026 Attendance |
|---|---|
University of California, San Francisco San Francisco, CA | |
Public research university and health sciences campus in San Francisco. | Talk Wed Dec 9 8:09–8:12am Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 12:30–2pm Poster Wed Dec 9 12:30–2pm Session Wed Dec 9 1–2:15pm Talk Wed Dec 9 3:30–4pm Poster Wed Dec 9 5–6:30pm Poster Wed Dec 9 5–6:30pm Poster Wed Dec 9 5–6:30pm Poster Wed Dec 9 5–6:30pm Session Thu Dec 10 7–8:30am Session Thu Dec 10 7–8:30am Talk Thu Dec 10 8:12–8:15am Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm Talk Thu Dec 10 1–1:08pm Talk Thu Dec 10 1:08–1:16pm Talk Thu Dec 10 1:15–1:30pm Poster Thu Dec 10 5–6:30pm Poster Thu Dec 10 5–6:30pm Talk Fri Dec 11 7:36–7:39am Talk Fri Dec 11 10:15–10:30am Session Fri Dec 11 noon–1pm Talk Fri Dec 11 noon–12:10pm Poster Fri Dec 11 12:30–2pm |
Find buyers in hereditary risk and genetic testing
Tell us what you sell and we’ll find the people at organizations working on hereditary risk and genetic testing most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse SABCS 2026 by
- Genomic and tumor testing 160
- Hormone receptor-positive breast cancer 157
- Triple-negative breast cancer 99
- Patient and family support 96
- Breast surgery and biopsy 93
- HER2-positive breast cancer 81
- Hereditary risk and genetic testing 64
- AI and data 60
- Clinical trials and research 58
- Metastatic breast cancer 54
- Side effects and supportive care 46
- Screening and early detection 39
- Liquid biopsy and MRD 11
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction